BRADENTON, Fla., Nov. 7 WellSpring PharmaceuticalCorporation, a growing North American-based pharmaceutical manufacturer, todayannounced that Wayne Miller has been hired as the Vice President, Sales andMarketing, Consumer Brands.
Mr. Miller, an accomplished sales executive, will be responsible fordesigning and implementing the Company's sales and marketing strategy in theUnited States for its newly acquired over-the-counter product line, whichincludes Micatin (R) (antifungal), Emetrol (R) (anti-nausea), and Gelusil (R)(antacid). Mr. Miller will also lead the United States launch of two productsthat the Company currently markets in Canada, Glaxal Base(TM) and Barriere.
Mr. Miller most recently held the position of Vice President, Sales andMarketing for a North American based over-the-counter consumer health company,Origin BioMed. During his tenure with Origin BioMed, Mr. Miller was thedriving force behind the successful launch of products into North America,gaining entry into several national and regional drug chains, as well asnegotiating viable relationships with the North American drug wholesalers,including AmerisourceBergen, McKesson and Cardinal Health.
Along with his team at Origin BioMed, Mr. Miller was recently awarded aNova Scotia Professional Sales Award for Innovative Sales Team. These awardshonor polished professional salespeople who are changing the perception of theprofession and are the driving force behind their organization's success.
"Mr. Miller is a valuable addition to our team. We are pleased to havehim lead our Consumer Brands Sales and Marketing group," said Dr. RobertVukovich, WellSpring's CEO and President. "His leadership experience, coupledwith an innovative and energetic approach, makes him ideally suited to directand guide our consumer health business."
About the Company
WellSpring Pharmaceutical Corp. has made the development, marketing andsales of new and novel prescription and OTC drug products its strategic focus.WellSpring's prescription drug products include Dyrenium (R) (diuretic) andDibenzyline (R) (anti-hypertension) which are marketed in the US. The firm isan active acquirer of pharmaceutical brands and enhances their value throughthe development of product improvements and line extensions.
WellSpring is a privately held pharmaceutical company founded in 1999 byDr. Robert A. Vukovich the firm's CEO and Chairman. Dr. Vukovich previouslyfounded and managed Roberts Pharmaceutical Corporation of Eatontown, NJ untilits acquisition by Shire Pharmaceutical Group in 1999. WellSpring owns andoperates an FDA approved manufacturing plant in Oakville, Ontario, Canada.Its administrative headquarters are located in Bradenton, Florida. The firmprovides contract manufacturing services to the pharmaceutical industry andmanufactures prescription and OTC drug products for both the US and Canada.
Dr. Robert A. Vukovich, +1-941-552-7880, or +1-941-504-1229, orWendy Shusko, +1-941-552-7881.
WellSpring Websites: www.wellspringpharm.com, www.wpcoutsourcing.com,www.wellskin.ca.
Information regarding several of the newly acquired brands can be found atthe following web addresses: www.micatin.com, www.gelusil.com andwww.emetrol.com.
SOURCE WellSpring Pharmaceutical Corporation